0001140361-20-021163.txt : 20200922 0001140361-20-021163.hdr.sgml : 20200922 20200922163701 ACCESSION NUMBER: 0001140361-20-021163 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20200917 FILED AS OF DATE: 20200922 DATE AS OF CHANGE: 20200922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ADVENT INTERNATIONAL CORP/MA CENTRAL INDEX KEY: 0001034196 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201189889 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 6179510555 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII Limited Partnership CENTRAL INDEX KEY: 0001556190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201189890 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII 2014 Limited Partnership CENTRAL INDEX KEY: 0001616578 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201189891 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617 951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII-A 2014 Limited Partnership CENTRAL INDEX KEY: 0001616577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201189892 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9493 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII Cayman Limited Partnership CENTRAL INDEX KEY: 0001561808 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201189893 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII 2014 Cayman Limited Partnership CENTRAL INDEX KEY: 0001616563 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201189894 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9493 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII-B Cayman Limited Partnership CENTRAL INDEX KEY: 0001563878 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201189895 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII-A Cayman Limited Partnership CENTRAL INDEX KEY: 0001559260 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201189896 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII-A Limited Partnership CENTRAL INDEX KEY: 0001559259 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201189897 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII-A 2014 Cayman Limited Partnership CENTRAL INDEX KEY: 0001616564 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201189898 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9493 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syneos Health, Inc. CENTRAL INDEX KEY: 0001610950 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 273403111 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-876-9300 MAIL ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: INC Research Holdings, Inc. DATE OF NAME CHANGE: 20140616 4/A 1 form4.xml FORM 4 X0306 4/A 2020-09-17 2020-09-21 0001610950 Syneos Health, Inc. SYNH 0001034196 ADVENT INTERNATIONAL CORP/MA PRUDENTIAL TOWER, 800 BOYLSTON STREET SUITE 3300 BOSTON MA 02199-8069 true 0001556190 Advent Partners GPE VII Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001616578 Advent Partners GPE VII 2014 Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001616577 Advent Partners GPE VII-A 2014 Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001561808 Advent Partners GPE VII Cayman Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001616563 Advent Partners GPE VII 2014 Cayman Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001563878 Advent Partners GPE VII-B Cayman Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001559260 Advent Partners GPE VII-A Cayman Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001559259 Advent Partners GPE VII-A Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001616564 Advent Partners GPE VII-A 2014 Cayman Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true Class A Common Stock 2020-09-17 4 S 0 3766281 59.26 D 18647036 I See Notes See Exhibit 99.1 for text of footnote (1). See Exhibit 99.1 for text of footnote (2). See Exhibit 99.1 for text of footnote (3). See Exhibit 99.1 for text of footnote (4). Exhibit 99.1 (Footnotes to Form 4) and Exhibit 99.2 (Signatures and Joint Filer Information) are incorporated herein by reference. This Amendment to Form 4 (this "Form 4/A") is being filed solely to correct certain errors in the text of the footnotes of the original Form 4 filing. This Form 4/A is the third of six Form 4/As being filed relating to the same event. This Form 4/A has been split into six filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10. Each part will be filed by Designated Filer, Advent International Corporation. See Exhibit 99.2 2020-09-22 EX-99.1 2 ex99-1.htm EXHIBIT 99.1
Exhibit 99.1

Name and Address of Reporting Person:
Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required to be Reported:
September 17, 2020
(Month/Day/Year)

Footnotes to Form 4

(1) Represents shares of Class A Common Stock (“Common Stock”) of Syneos Health, Inc. (the “Issuer”) sold in connection with a secondary offering of the Issuer’s Common Stock by the following entities: 64,358 shares sold by Advent International GPE VIII-C Limited Partnership (“GPE VIII-C”) and 3,701,923 shares sold by Double Eagle Investor Holdings, L.P. (“Double Eagle Investor Holdings”), of which: 768 shares were indirectly sold by Advent Partners GPE VII Limited Partnership, 1,966 shares were indirectly sold by Advent Partners GPE VII 2014 Limited Partnership, 1,815 shares were indirectly sold by Advent Partners GPE VII-A Limited Partnership, 5,390 shares were indirectly sold by Advent Partners GPE VII-A 2014 Limited Partnership, 13,091 shares were indirectly sold by Advent Partners GPE VII (Cayman) Limited Partnership, 4,425 shares were indirectly sold by Advent Partners GPE VII 2014 Cayman Limited Partnership, 3,461 shares were indirectly sold by Advent Partners GPE VII-A (Cayman) Limited Partnership, 17,946 shares were indirectly sold by Advent Partners GPE VII-B (Cayman) Limited Partnership, 3,122 shares were indirectly sold by Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership (collectively, the “Advent Partners GPE VII Funds”); 163,901 shares were indirectly sold by Advent International GPE VII-A Limited Partnership, 363,643 shares were indirectly sold by Advent International GPE VII-E Limited Partnership, 28,424 shares were indirectly sold by Advent International GPE VII-H Limited Partnership (collectively, the “GPE VII GP Funds”); 177,079 shares were indirectly sold by Advent International GPE VII Limited Partnership, 504,842 shares were indirectly sold by Advent International GPE VII-B Limited Partnership, 160,432 shares were indirectly sold by Advent International GPE VII-C Limited Partnership, 106,020 shares were indirectly sold by Advent International GPE VII-D Limited Partnership, 46,815 shares were indirectly sold by Advent International GPE VII-F Limited Partnership, 46,815 shares were indirectly sold by Advent International GPE VII-G Limited Partnership (collectively, the “GPE VII GP S.a.r.l. Funds”); 119,301 shares were indirectly sold by Advent International GPE VIII Limited Partnership, 395,173 shares were indirectly sold by Advent International GPE VIII-B Limited Partnership, 140,226 shares were indirectly sold by Advent International GPE VIII-B-1 Limited Partnership, 104,552 shares were indirectly sold by Advent International GPE VIII-B-2 Limited Partnership, 163,261 shares were indirectly sold by Advent International GPE VIII-B-3 Limited Partnership, 55,040 shares were indirectly sold by Advent International GPE VIII-D Limited Partnership, 16,312 shares were indirectly sold by Advent International GPE VIII-F Limited Partnership, 144,509 shares were indirectly sold by Advent International GPE VIII-H Limited Partnership, 134,377 shares were indirectly sold by Advent International GPE VIII-I Limited Partnership, 132,054 shares were indirectly sold by Advent International GPE VIII-J Limited Partnership (collectively, the “GPE VIII GP S.a.r.l. Funds”); 279,835 shares were indirectly sold by Advent International GPE VIII-A Limited Partnership, 61,300 shares were indirectly sold by Advent International GPE VIII-E Limited Partnership, 103,968 shares were indirectly sold by Advent International GPE VIII-G Limited Partnership, 57,217 shares were indirectly sold by Advent International GPE VIII-K Limited Partnership, 56,309 shares were indirectly sold by Advent International GPE VIII-L Limited Partnership (collectively, the “GPE VIII GP Funds”); 27,494 shares were indirectly sold by Advent Partners GPE VIII Cayman Limited Partnership, 3,661 shares were indirectly sold by Advent Partners GPE VIII-A Cayman Limited Partnership, 47,037 shares were indirectly sold by Advent Partners GPE VIII-B Cayman Limited Partnership, 4,614 shares were indirectly sold by Advent Partners GPE VIII Limited Partnership, and 5,728 shares were indirectly sold by Advent Partners GPE VIII-A Limited Partnership (collectively, the “Advent Partners GPE VIII Funds”).

Page 1 of 2
(2) Following the offering, Advent manages funds that collectively own 18,647,036 shares, which are represented as follows: 318,642 shares held directly by GPE VIII-C and 18,328,394 shares held directly by Double Eagle Investor Holdings, of which: 3,804 shares are indirectly owned by Advent Partners GPE VII Limited Partnership, 9,735 shares are indirectly owned by Advent Partners GPE VII 2014 Limited Partnership, 8,988 shares are indirectly owned by Advent Partners GPE VII-A Limited Partnership, 26,684 shares are indirectly owned by Advent Partners GPE VII-A 2014 Limited Partnership, 64,816 shares are indirectly owned by Advent Partners GPE VII (Cayman) Limited Partnership, 21,911 shares are indirectly owned by Advent Partners GPE VII 2014 Cayman Limited Partnership, 17,136 shares are indirectly owned by Advent Partners GPE VII-A (Cayman) Limited Partnership, 88,853 shares are indirectly owned by Advent Partners GPE VII-B (Cayman) Limited Partnership, 15,460 shares are indirectly owned by Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership; 811,482 shares are indirectly owned by Advent International GPE VII-A Limited Partnership, 1,800,408 shares are indirectly owned by Advent International GPE VII-E Limited Partnership, 140,729 shares are indirectly owned by Advent International GPE VII-H Limited Partnership; 876,728 shares are indirectly owned by Advent International GPE VII Limited Partnership, 2,499,483 shares are indirectly owned by Advent International GPE VII-B Limited Partnership, 794,309 shares are indirectly owned by Advent International GPE VII-C Limited Partnership, 524,913 shares are indirectly owned by Advent International GPE VII-D Limited Partnership, 231,782 shares are indirectly owned by Advent International GPE VII-F Limited Partnership, 231,782 shares are indirectly owned by Advent International GPE VII-G Limited Partnership; 590,664 shares are indirectly owned by Advent International GPE VIII Limited Partnership, 1,956,521 shares are indirectly owned by Advent International GPE VIII-B Limited Partnership, 694,268 shares are indirectly owned by Advent International GPE VIII-B-1 Limited Partnership, 517,642 shares are indirectly owned by Advent International GPE VIII-B-2 Limited Partnership, 808,312 shares are indirectly owned by Advent International GPE VIII-B-3 Limited Partnership, 272,508 shares are indirectly owned by Advent International GPE VIII-D Limited Partnership, 80,760 shares are indirectly owned by Advent International GPE VIII-F Limited Partnership, 715,468 shares are indirectly owned by Advent International GPE VIII-H Limited Partnership, 665,308 shares are indirectly owned by Advent International GPE VIII-I Limited Partnership, 653,803 shares are indirectly owned by Advent International GPE VIII-J Limited Partnership; 1,385,475 shares are indirectly owned by Advent International GPE VIII-A Limited Partnership, 303,499 shares are indirectly owned by Advent International GPE VIII-E Limited Partnership, 514,751 shares are indirectly owned by Advent International GPE VIII-G Limited Partnership, 283,286 shares are indirectly owned by Advent International GPE VIII-K Limited Partnership, 278,791 shares are indirectly owned by Advent International GPE VIII-L Limited Partnership; 136,123 shares are indirectly owned by Advent Partners GPE VIII Cayman Limited Partnership, 18,124 shares are indirectly owned by Advent Partners GPE VIII-A Cayman Limited Partnership, 232,883 shares are indirectly owned by Advent Partners GPE VIII-B Cayman Limited Partnership, 22,843 shares are indirectly owned by Advent Partners GPE VIII Limited Partnership, and 28,362 shares are indirectly owned by Advent Partners GPE VIII-A Limited Partnership.

(3) Advent is the Sole Member of Double Eagle GP, LLC, which in turn is the General Partner of Double Eagle Investor Holdings. Advent is the Manager of Advent International GPE VII, LLC (“GPE VII LLC”) and Advent International GPE VIII, LLC (“GPE VIII LLC”).

GPE VII, LLC is the General Partner of GPE VII GP S.a.r.l. (“GPE VII GP S.a.r.l.”), GPE VII GP Limited Partnership (“GPE VII GP”), and the Advent Partners GPE VII Funds. GPE VII GP is the General Partner of the GPE VII GP Funds. GPE VII GP S.a.r.l. is the General Partner of the GPE VII GP S.a.r.l. Funds.

GPE VIII LLC is the General Partner of GPE VIII GP Limited Partnership (“GPE VIII GP”), GPE VIII GP S.a.r.l. (“GPE VIII GP S.a.r.l.”), and AP GPE VIII GP Limited Partnership (“AP GPE VIII GP”). GPE VIII GP S.a.r.l. is the General Partner of the GPE VIII GP S.a.r.l. Funds and of GPE VIII-C. GPE VIII GP is the General Partner of the GPE VIII GP Funds. AP GPE VIII GP is the General Partner of the Advent Partners GPE VIII Funds.

(4) Each of the entities named above are referred to herein as “Reporting Persons.” Each Reporting Person disclaims Section 16 beneficial ownership of the shares reported herein except to the extent of its respective pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or any other purpose.

Page 2 of 2


 EX-99.2 3 ex99-2.htm EXHIBIT 99.2
Exhibit 99.2

Joint Filer Information


Name of Joint Filer:
Double Eagle Investor Holdings, L.P.

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

DOUBLE EAGLE INVESTOR HOLDINGS, L.P.
By: Double Eagle GP, LLC, its General Partner
By: Advent International Corporation, its Sole Member


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 1 of 48
Joint Filer Information


Name of Joint Filer:
Double Eagle GP, LLC

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

DOUBLE EAGLE GP, LLC
By: Advent International Corporation, its Sole Member


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 2 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII-C Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-C LIMITED PARTNERSHIP

 
By: GPE VIII GP S.à r.l., its General Partner
 
By: Advent International GPE VIII, LLC, its Manager
/s/                 Justin Nuccio
  
By: Advent International Corporation, its Manager
 Justin Nuccio, Manager  


By:
/s/                 Michael Ristaino

Name: Michael Ristaino
Title:  Vice President of Finance – Fund Administration


September 21, 2020
Date
 


 
Page 3 of 48
Joint Filer Information


Name of Joint Filer:
GPE VIII GP S.à r.l.

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

GPE VIII GP S.à r.l.

 
By: Advent International GPE VIII, LLC, its Manager
/s/                 Justin Nuccio
  
By: Advent International Corporation, its Manager
 Justin Nuccio, Manager  


By:
/s/                 Michael Ristaino

Name: Michael Ristaino
Title:  Vice President of Finance – Fund Administration

September 21, 2020
Date
 
Page 4 of 48
Joint Filer Information


Name of Joint Filer:
GPE VIII GP Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

GPE VIII GP LIMITED PARTNERSHIP
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 5 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII, LLC

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII, LLC
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 6 of 48
Joint Filer Information


Name of Joint Filer:
GPE VII GP S.à r.l.

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

GPE VII GP S.à r.l.

 
By: Advent International GPE VIII, LLC, its Manager
/s/                 Justin Nuccio
  
By: Advent International Corporation, its Manager
 Justin Nuccio, Manager  


By:
/s/                 Michael Ristaino

Name: Michael Ristaino
Title:  Vice President of Finance – Fund Administration

September 21, 2020
Date
 
Page 7 of 48
Joint Filer Information


Name of Joint Filer:
GPE VII GP Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

GPE VII GP LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 8 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VII, LLC

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII, LLC
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
Page 9 of 48
Joint Filer Information


Name of Joint Filer:
AP GPE VIII GP Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

AP GPE VIII GP LIMITED PARTNERSHIP
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 10 of 48
Joint Filer Information


Name of Joint Filer:
Advent Partners GPE VIII Cayman Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII CAYMAN LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 11 of 48
Joint Filer Information


Name of Joint Filer:
Advent Partners GPE VIII-B Cayman Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII-B CAYMAN LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 12 of 48
Joint Filer Information


Name of Joint Filer:
Advent Partners GPE VIII Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 13 of 48
Joint Filer Information


Name of Joint Filer:
Advent Partners GPE VIII-A Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII-A LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 14 of 48
Joint Filer Information


Name of Joint Filer:
Advent Partners GPE VIII-A Cayman Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII-A CAYMAN LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 15 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VII-A Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-A LIMITED PARTNERSHIP
By: GPE VII GP Limited Partnership, its General Partner
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 16 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VII-E Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-E LIMITED PARTNERSHIP
By: GPE VII GP Limited Partnership, its General Partner
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 17 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VII-H Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-H LIMITED PARTNERSHIP
By: GPE VII GP Limited Partnership, its General Partner
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
Page 18 of 48
Joint Filer Information


Name of Joint Filer:
Advent Partners GPE VII Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 19 of 48
Joint Filer Information


Name of Joint Filer:
Advent Partners GPE VII 2014 Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII 2014 LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 20 of 48
Joint Filer Information


Name of Joint Filer:
Advent Partners GPE VII-A Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 21 of 48
Joint Filer Information


Name of Joint Filer:
Advent Partners GPE VII-A 2014 Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A 2014 LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 22 of 48
Joint Filer Information


Name of Joint Filer:
Advent Partners GPE VII Cayman Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 23 of 48
Joint Filer Information


Name of Joint Filer:
Advent Partners GPE VII 2014 Cayman Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII 2014 CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 24 of 48
Joint Filer Information


Name of Joint Filer:
Advent Partners GPE VII-A Cayman Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 25 of 48
Joint Filer Information


Name of Joint Filer:
Advent Partners GPE VII-B Cayman Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-B CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 26 of 48
Joint Filer Information


Name of Joint Filer:
Advent Partners GPE VII-A 2014 Cayman Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A 2014 CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 27 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 28 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII-B Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 29 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII-B-1 Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B-1 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 30 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII-B-2 Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B-2 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 31 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII-B-3 Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B-3 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 32 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII-D Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-D LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 33 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII-F Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-F LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 34 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII-H Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-H LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 35 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII-I Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-I LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 

Page 36 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII-J Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-J LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 37 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII-A Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-A LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 38 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII-E Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-E LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 39 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII-G Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-G LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 40 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII-K Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-K LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 41 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VIII-L Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-L LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager


By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 

Page 42 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VII Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 43 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VII-B Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-B LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 44 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VII-C Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-C LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 45 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VII-D Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-D LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 46 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VII-F Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-F LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 
Page 47 of 48
Joint Filer Information


Name of Joint Filer:
Advent International GPE VII-G Limited Partnership

Address of Joint Filer:
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199-8069

Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
September 17, 2020

Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-G LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
 
/s/                 Justin Nuccio
 
By: Advent International Corporation, its Manager
 
 Justin Nuccio, Manager
 

By:
/s/                 Michael Ristaino
  
Name: Michael Ristaino
  
Title:  Vice President of Finance – Fund Administration
  


September 21, 2020
Date
 


Page 48 of 48